Latest Health News

Page 153 of 171
Argenica Therapeutics has reported compelling preclinical data showing ARG-007 significantly reduces brain cell damage and inflammation in moderate traumatic brain injury, matching levels seen in uninjured controls. This reinforces ARG-007’s potential as a breakthrough neuroprotective therapy.
Ada Torres
Ada Torres
4 Feb 2025
Beamtree Holdings appoints Marek Stepniak as CEO, signaling a strategic push in international markets with a strong leadership hand familiar with the company’s growth trajectory.
Ada Torres
Ada Torres
4 Feb 2025
Micro-X Limited has requested an immediate voluntary suspension of its shares on the ASX, pending a forthcoming equity raising announcement expected by February 10.
Ada Torres
Ada Torres
4 Feb 2025
OncoSil Medical has secured authorization for 120 German hospitals to negotiate funding for its pancreatic cancer treatment device, marking a 43% increase from last year and signaling growing acceptance in Germany’s healthcare system.
Victor Sage
Victor Sage
4 Feb 2025
Aeris Environmental has updated its quarterly cash flow report, confirming ongoing operational cash outflows but expressing confidence in maintaining current cash flow levels while exploring new funding avenues.
Maxwell Dee
Maxwell Dee
3 Feb 2025
Regis Resources has established a $300 million revolving credit facility, replacing its previous term loan to enhance financial flexibility and liquidity amid a strong banking syndicate backing.
Victor Sage
Victor Sage
3 Feb 2025
Maas Group Holdings has announced a fresh on-market share buyback of up to 10% of its issued capital, signaling strong confidence in its financial health and future prospects.
Victor Sage
Victor Sage
3 Feb 2025
Viridis Mining and Minerals Limited has requested an immediate voluntary suspension of its shares pending a capital raising announcement, signaling a pivotal moment for the company.
Maxwell Dee
Maxwell Dee
3 Feb 2025
Sandon Capital Investments announces a fully franked 1.4 cents per share dividend for the March quarter, reflecting a robust annualised yield of 6.9% and underpinned by strong portfolio returns of 17.7% for FY2025 to date.
Claire Turing
Claire Turing
3 Feb 2025
Optiscan Imaging has initiated a pivotal pre-clinical gastrointestinal study in Germany using its first flexible prototype, aiming to revolutionize real-time GI tract imaging and diagnostics.
Ada Torres
Ada Torres
3 Feb 2025
ResMed Inc. reported robust financial results for the quarter ended December 31, 2024, with a 10% increase in net revenue and a 65% jump in net income, driven by strong demand across its Sleep and Breathing Health and Residential Care Software segments.
Ada Torres
Ada Torres
3 Feb 2025
DomaCom Limited reports a transformative quarter with executive changes, new funding facilities, and strategic initiatives including the launch of its Homeowner Equity Fund and exclusive licensing of the Bricklet Homeowner Platform.
Claire Turing
Claire Turing
3 Feb 2025